Other languages Inovio Pharmaceuticals, Inc.

Equities

INO

US45773H4092

Market Closed - Nasdaq Other stock markets 04:00:00 2024-05-31 pm EDT			5-day change	1st Jan Change
10.13 ^USD	+3.68%		-7.91%	+65.52%

May. 14	Stephens Starts Inovio Pharmaceuticals With Overweight Rating, $20 Price Target	MT
May. 13	Transcript : Inovio Pharmaceuticals, Inc., Q1 2024 Earnings Call, May 13, 2024

Other languages

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

INOVIO Reports Inducement Grants Under Inducement Plan	May. 31
Stephens Starts Inovio Pharmaceuticals With Overweight Rating, $20 Price Target	May. 14
Inovio: Q1 Earnings Snapshot	May. 13
Transcript : Inovio Pharmaceuticals, Inc., Q1 2024 Earnings Call, May 13, 2024	May. 13
INOVIO Reports First Quarter 2024 Financial Results and Recent Business Highlights	May. 13
Inovio Pharmaceuticals, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024	May. 13
INOVIO Reports Inducement Grants Under Inducement Plan	May. 01
INOVIO to Report First Quarter 2024 Financial Results on May 13, 2024	Apr. 29
INOVIO to Participate in Upcoming Investor Conferences in May	Apr. 29
Powell Comments, Middle East Tensions in Focus as US Equity Futures Gain Pre-Bell	Apr. 16
Inovio Pharmaceuticals Shares Slump Pre-Bell After Pricing of $36 Million Offering of Common Stock, Warrants	Apr. 16
Top Premarket Decliners	Apr. 16
INOVIO Announces Pricing of Approximately $36 Million Underwritten Offering of Common Stock and Pre-Funded Warrants	Apr. 15
INOVIO to Participate in The Citizens JMP Novel Therapeutics Forum at Penn Medicine	Mar. 26
INOVIO Reports Fourth Quarter and Full Year 2023 Financial Results and Operational Highlights	Mar. 07
Transcript : Inovio Pharmaceuticals, Inc., Q4 2023 Earnings Call, Mar 06, 2024	Mar. 06
Inovio Pharmaceuticals, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	Mar. 06
INOVIO to Report Fourth Quarter and Year-End 2023 Financial Results on March 6, 2024	Feb. 21
INOVIO to Present at the Oppenheimer 34th Annual Healthcare Life Sciences Conference	Feb. 07
INOVIO Reports Inducement Grant Under Inducement Plan	Feb. 02

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Other languages Inovio Pharmaceuticals, Inc.

Equities

INO

US45773H4092

Other languages

Filters